Dr. Michael B. Bobrow, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Rochester School of Medicine and Dentistry (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 327
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Rochester School of Medicine and Dentistry
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
NY license 210151 -
Pediatric Dermatology Physician
NY license 210151 -
Procedural Dermatology Physician
NY license 210151
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Rochester General Hospital Rochester, NY
Medical groups
- Greece Dermatological Associates PC (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 327
- Services billed
- 1,263
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 421 | 83 |
| Established patient office or other outpatient visit, 20-29 minutes | 269 | 203 |
| Established patient office or other outpatient visit, 30-39 minutes | 167 | 125 |
| Destruction of precancer skin growth, 1 growth | 162 | 131 |
| Destruction of skin growth, 1-14 growths | 78 | 69 |
| Biopsy of related skin growth, first growth | 57 | 51 |
| New patient office or other outpatient visit, 30-44 minutes | 15 | 15 |
| Destruction of precancer skin growth, 15 or more growths | 15 | 14 |
| Biopsy of related skin growth, each additional growth | 13 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clobetasol Propionate Other prescribers in Rochester, NY | 176 |
| Econazole Nitrate | 128 |
| Fluocinonide Other prescribers in Rochester, NY | 125 |
| Metronidazole Other prescribers in Rochester, NY | 82 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Rochester, NY | 68 |
| Desonide | 66 |
| Tacrolimus Other prescribers in Rochester, NY | 62 |
| Mupirocin Other prescribers in Rochester, NY | 51 |
| Triamcinolone Acetonide Other prescribers in Rochester, NY | 50 |
| Alclometasone Dipropionate | 42 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 18 payments worth $416 in total to this clinician.
| AbbVie Inc. | $73.50 |
|---|---|
| Genzyme Corporation | $71.48 |
| UCB, Inc. | $53.81 |
| Galderma Laboratories, L.P. | $46.47 |
| Amgen Inc. | $46.37 |
| Janssen Biotech, Inc. | $30.30 |
| Lilly USA, LLC | $27.17 |
| Genentech USA, Inc. | $23.10 |
| Food and Beverage | $416 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.